The drug in question is produced in South Africa by manufacturer Pharmacare Lennon before being shipped to Hong Kong.
The Hong Kong Department of Health (DoH) said it had ordered the recall after “[finding] that [Julius Chen] illegally stored medicines and was involved in illegal packaging of pharmaceutical products without manufacturing license.”
The regulatory agency explained that pharmaceuticals imported to Hong Kong by wholesalers are required to be packaged by local licensed good manufacturing practices (GMP) manufacturers before distributing to users and retail outlets.